NCT04206748NARecruitingAccepts Healthy Volunteers

iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes

The University of Texas Health Science Center, Houston

Start Date

11/12/2019

Completion Date

11/1/2022

Summary

The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria * All patients \>/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks. * Non-anomalous singletons * Ability to provide informed consent Exclusion Criteria * Patients with Type 1 diabetes * Patients with fetal major congenital abnormalities * Patients identified/referred after 30.6 weeks

Interventions

DEVICE

iGlucose Smart Meter System

DEVICE

Routine Care-RX meter

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Gestational DiabetesType2 DiabetesPregnancy in Diabetic

Locations

The University of Texas Health Science Center at Houston

Houston, Texas 77030

United States